PATENT CLAIM ANALYSIS

Application Number: 16423252
Application Type: Utility
Filing Date: 2019-05
Publication Date: 2019-09
Patent Classification: ["546", "198000"]

Abstract:
The present invention relates to novel fatty acid esters of the reversible Iloperidone metabolite P-88-8991, their preparation, their use as pharmaceuticals and pharmaceutical compositions containing them.

Claim (Index 7):
The pharmaceutical composition of  claim 6 , wherein the compound of Formula I is decanoic acid 1-(4-{3-[4-(6-fluoro-benzo[d]isoxazole-3-yl)-piperidine-1-yl]propoxy}-3-methoxy-phenyl)-ethyl ester.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 100.0
- Lexical Diversity: 1.07407
- Patent Class: 546.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15481565', '13462187', '10637900', '14877972', '15697867']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.76648211471177
- 35 USC 102 Novelty (BERT): 0.4711857362386115
- Combined Prediction Score: 0.7369524768644542
- Mean Citation Score: 151.355524
- Max Citation Score: 152.736
- Similarity Product: 110.01253914070128

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test